Gujarat Kidney and Super Speciality shareholders approved a special resolution to vary the objects and terms of utilisation of its initial public offering proceeds. The remote e-voting concluded on August 22, 2026, with the resolution passing by a near-unanimous margin.

The company informed the Bombay Stock Exchange and the National Stock Exchange that the voting process complied with Regulation 44(3) of the SEBI (LODR) Regulations, 2015. The scrutinizer, SPANJ & Associates, confirmed the results were declared on the same day as the voting closure.

Voting Breakdown

A total of 57 members participated in the remote e-voting process, casting votes on 56,902,667 shares. The promoters and promoter group, holding 56,333,900 shares, voted entirely in favour of the resolution.

Only one member abstained from voting, representing a single share. No votes were declared invalid during the scrutiny process conducted by Ashish Doshi of SPANJ & Associates.

Process Details

The postal ballot notice was dispatched electronically on July 22, 2026, to members registered as of the cut-off date on July 17, 2026. The e-voting window remained open from July 24, 2026, until August 22, 2026. The company published advertisements regarding the ballot in Financial Express and Gujarat Mitra newspapers to ensure wide dissemination among stakeholders.

Gujarat Kidney and Super Speciality reported a consolidated net profit of 52M rupees in Q1, up from 48M rupees in the corresponding period last year, reflecting year-on-year growth in profitability. Revenue for the quarter more than doubled on a year-on-year basis, climbing to 343M rupees from 153M rupees.

Q1 consolidated financial performance

The company's Q1 results show notable improvement across both the topline and bottom line compared to the year-ago period. The following table summarises the key financial metrics:

Revenue more than doubled year-on-year, rising from 153M rupees to 343M rupees, while net profit grew from 48M rupees to 52M rupees over the same period.